Retrospective Study
Copyright ©The Author(s) 2021.
World J Hepatol. Dec 27, 2021; 13(12): 2081-2103
Published online Dec 27, 2021. doi: 10.4254/wjh.v13.i12.2081
Table 2 Descriptive numerical data for the whole study population
Variable
Data
MELD score16 ± 4
Child score10 ± 2
Donors’ age (yr)27 ± 6
Donors’ BMI (kg/m2)24 ± 3
Recipient's age (yr)50 ± 8
Recipient's BMI (kg/m2)28 ± 4
Total bilirubin (mg/dL)2.6 (1.9-3.8)
Direct bilirubin (mg/dL)1.3 (0.7-2.1)
Alkaline phosphatase (IU/L)104 ± 48
Gamma-glutamyl transferase (IU/L)36 (19-61)
Platelets (109/L)79 ± 35
Cold ischemia time (min)49 ± 24
Warm ischemia time (min)48 ± 20
Graft arterialization time (min)141 ± 51
Time to biliary infection (d)16 (11-30)
Time to biliary stricture (d)150 (120-218)
Time to mortality (d)285 (55-808)
Time to chronic graft rejection (d)490 (230-920)
Time to recurrent HCV (d)391 (180-714)
Time to graft failure (d)556 (135-1267)